Top Markets
#1 Islamic Coin Islamic Coin +151.39%
#2 Akedo Akedo +72.13%
#3 Glidr Glidr +51.75%
#4 Velvet Velvet +50.79%
#5 DOVU DOVU +48.49%
#6 Cross Cross +35.04%
#7 Black Phoenix Black Phoenix +33.93%
#8 Cap Cap +19.07%
#9 DoubleZero DoubleZero +14.81%
#10 Movement Movement +9.74%
Coin of the day
Islamic Coin Islamic Coin
설정
언어
한국어
통화
USD
테마
THC Farmaceuticals, Inc. THC Farmaceuticals, Inc.

THC Farmaceuticals, Inc.

CBDG
주식 순위 #39419
THC Farmaceuticals, Inc. specializes in the ownership and operation of... THC Farmaceuticals, Inc. specializes in the ownership and operation of independent (non-bank) automated teller machines (ATMs), strategically placing them within third-party retail and commercial establishments. These cash-dispensing units are typically situated in bustling commercial spaces such as hotels, stores, and bowling alleys, aiming for high customer footfall areas that often serve small and medium-sized enterprises. By mid-2015 (June 30), the company reported a network of eight public-access ATMs concentrated in Utah's Wasatch Front region. Founded in 2008 and based in Scottsdale, Arizona, the company adopted its current name, THC Farmaceuticals, Inc., in February 2015, having previously operated as City Media, Inc. THC Farmaceuticals, Inc. functions as a subsidiary of Weed Growth Fund, Inc.
주가
$0.0279
마지막 동기화: 2026-08-12
시가총액
$505.87K
변동 (1일)
0.00%
변동 (1년)
-43.75%
국가
US
거래 THC Farmaceuticals, Inc. (CBDG)

카테고리

Healthcare
THC Farmaceuticals, Inc. (CBDG)의 수익
2026 기준 수익 TTM: 0
THC Farmaceuticals, Inc.의 최신 재무 보고서에 따르면 회사의 현재 수익은 0입니다. 2026년에 회사는 0의 수익을 올렸으며 이는 2026년의 수익 0과 동일입니다. 이 페이지에 표시된 수익은 이자 및 세금 공제 전 수익으로, 즉 EBIT입니다.
THC Farmaceuticals, Inc.의 수익 기록 (2026 ~ 2026)
연말 수익
연도 수익 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 수익
회사 수익 수익 차이 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE